Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$700.03 - $830.35 $485,120 - $575,432
693 Added 158.94%
1,129 $811,000
Q1 2023

May 12, 2023

SELL
$680.49 - $826.97 $118,405 - $143,892
-174 Reduced 28.52%
436 $358,000
Q4 2022

Feb 13, 2023

BUY
$705.89 - $766.39 $430,592 - $467,497
610 New
610 $440,000
Q2 2022

Aug 15, 2022

BUY
$548.35 - $738.84 $256,079 - $345,038
467 New
467 $276,000
Q1 2022

May 16, 2022

SELL
$595.12 - $698.43 $764,134 - $896,784
-1,284 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$543.48 - $670.97 $450,001 - $555,563
828 Added 181.58%
1,284 $811,000
Q3 2021

Nov 15, 2021

SELL
$574.03 - $680.96 $200,336 - $237,655
-349 Reduced 43.35%
456 $276,000
Q2 2021

Aug 16, 2021

SELL
$472.8 - $558.54 $115,363 - $136,283
-244 Reduced 23.26%
805 $450,000
Q1 2021

May 17, 2021

BUY
$446.73 - $548.2 $126,871 - $155,688
284 Added 37.12%
1,049 $496,000
Q4 2020

Feb 16, 2021

BUY
$478.3 - $607.98 $365,899 - $465,104
765 New
765 $370,000
Q3 2020

Nov 16, 2020

SELL
$544.75 - $658.21 $341,558 - $412,697
-627 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$493.32 - $643.92 $309,311 - $403,737
627 New
627 $391,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Echo Street Capital Management LLC Portfolio

Follow Echo Street Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Echo Street Capital Management LLC with notifications on news.